Trial Profile
Proof Of Concept Study of Yuxintine in the Treatment of Major Depressive Disorder(MDD): a Randomized, Double-Blind, Placebo-Paralleled,Dose-Finding, Multicenter Clinical Trial
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs S 111 (Primary)
- Indications Major depressive disorder
- Focus Proof of concept; Therapeutic Use
- 08 Jan 2016 New trial record